Filing Details

Accession Number:
0001209191-20-031299
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-21 16:37:07
Reporting Period:
2020-05-19
Accepted Time:
2020-05-21 16:37:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674416 Crispr Therapeutics Ag CRSP Biological Products, (No Disgnostic Substances) (2836) 473173478
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682017 Rodger Novak C/O Crispr Therapeutics, Inc.
610 Main Street
Cambridge MA 02139
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2020-05-19 50,000 $65.00 798,007 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.